In line with our findings, preclinical studies have shown that tumor regression induced by cancer vaccines is dependent on IL-6 signaling in macrophages [6], as the reduction in SOCS3 expression in the absence of IL-6 polarized TAMs toward an anti-inflammatory state that significantly impaired the efficacy of cancer vaccines [6]. This evidence concerns the gene IL6 and cancer.